Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) Gross Margin (2020 - 2022)

SELLAS Life Sciences (SLS) has disclosed Gross Margin for 3 consecutive years, with 90.0% as the latest value for Q1 2022.

  • On a quarterly basis, Gross Margin fell 825.0% to 90.0% in Q1 2022 year-over-year; TTM through Dec 2022 was 90.0%, a 737.0% decrease, with the full-year FY2022 number at 90.0%, down 737.0% from a year prior.
  • Gross Margin was 90.0% for Q1 2022 at SELLAS Life Sciences, down from 94.74% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 100.0% in Q4 2020 to a low of 90.0% in Q1 2022.
  • A 3-year average of 95.75% and a median of 96.49% in 2021 define the central range for Gross Margin.
  • Biggest YoY gain for Gross Margin was -825bps in 2022; the steepest drop was -825bps in 2022.
  • SELLAS Life Sciences' Gross Margin stood at 100.0% in 2020, then decreased by -5bps to 94.74% in 2021, then decreased by -5bps to 90.0% in 2022.
  • Per Business Quant, the three most recent readings for SLS's Gross Margin are 90.0% (Q1 2022), 94.74% (Q2 2021), and 98.25% (Q1 2021).